Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis-Reference-Cited by-同舟云学术

Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis

Published:2012-04 Issue:4 Volume:10 Page:391-399.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Hyams Jeffrey,Damaraju Lakshmi,Blank Marion,Johanns Jewel,Guzzo Cynthia,Winter Harland S.,Kugathasan Subra,Cohen Stanley,Markowitz James,Escher Johanna C.,Veereman–Wauters Gigi,Crandall Wallace,Baldassano Robert,Griffiths Anne

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference20 articles.

1. Inflammatory bowel disease in pediatric and adolescent patients;Baldassano;Gastroenterol Clin North Am,1999

2. Inflammatory bowel disease: the difference between children and adults;Kelsen;Inflamm Bowel Dis,2008

3. Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD;Sauer;Gastroenterol Clin North Am,2009

4. Acute severe ulcerative colitis in children: a systematic review;Turner;Inflamm Bowel Dis,2011

5. The natural history of corticosteroid therapy for ulcerative colitis in children;Hyams;Clin Gastroenterol Hepatol,2006

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31

2. Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing;Intestinal Research;2024-07-31

3. Therapeutic options for children and young people with moderate-to-severe ulcerative colitis;Frontline Gastroenterology;2024-07-13

4. Diagnosis and management of inflammatory bowel disease;Journal of Evidence-Based Medicine;2024-06

5. Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN;Pediatric Drugs;2024-05-23